A Study of CCX168 in Japanese and Caucasian Healthy Adult Males

Clinical trial NCT05988008 · COMPLETED

Trial details

NCT number: NCT05988008
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

Start date: 2017-10-23
Primary completion: 2018-01-26
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.